Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: NOVOGENE CORPORATION INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-07-06 to 2023-12-06
Current total value of award: $0
Description: SINGLE CELL RNA SEQUENCING ANALYSIS TO INVESTIGATE THE ROLE OF GPR110 IN CELL TYPE SPECIFIC NEUROGENESIS